Two Sigma Securities’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-11,684
Closed -$9.93K 3831
2023
Q4
$9.93K Buy
+11,684
New +$11.3K ﹤0.01% 2815

Other funds holding VAXX

Two Sigma Securities's VAXX Position: Q1 2024 in Review

Two Sigma Securities sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q1 2024, closing a stake of 11,684 shares — an estimated $9.93K sold.

Two Sigma Securities first reported a position in VAXX in Q4 2023 and held it in 1 quarter. The position peaked at $9.93K in Q4 2023. 58 funds tracked by Wall St. Rank hold VAXX as of Q1 2024.

  • Two Sigma Securities reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Securities sold 11,684 Vaxxinity, Inc. Class A Common Stock shares in Q1 2024, an estimated $9.93K.
  • Two Sigma Securities first reported a position in Vaxxinity, Inc. Class A Common Stock in Q4 2023 and held it in 1 quarter.
  • Two Sigma Securities's Vaxxinity, Inc. Class A Common Stock position peaked at $9.93K in Q4 2023.
  • 58 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q1 2024.

Based on Two Sigma Securities's 13F filing for Q1 2024, filed 15 May 2024.